Chronic spontaneous urticaria (CSU) has a significant impact on quality of life. Insights into the pathophysiology of CSU have led to the development of novel targeted therapies that can improve outcomes for patients with this debilitating condition. Tune in to this live national webinar where leading experts will discuss these updates and answer your most pressing questions about the latest advances in CSU treatment.